Clinical Trial Update: A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream [Phase 1]

View source ↗

Summary

Phase I single-dose exploratory study in healthy volunteers to evaluate safety and pharmacokinetics of GSK2894512 cream for atopic dermatitis; the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GSK2894512 cream (GSK2894512)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED